Search clinical trials for: Tusamitamab ravtansine
Total 145 results
-
Erasmus Medical CenterSanofiWithdrawnMetastatic Lung Cancer | Metastatic Breast Cancer | Metastatic Gastric CancerNetherlands
-
SanofiTerminatedNeoplasmFrance, United States, Belgium, Spain, Turkey
-
SanofiActive, not recruitingNon-squamous Non-small Cell Lung CancerBelgium, Italy, Spain, Japan, United States, France, Turkey
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingNon-squamous Non-small-cell Lung CancerChina
-
SanofiActive, not recruitingNon-squamous Non-small-cell Lung Cancer (NSQ NSCLC)Spain, United States, Brazil, Chile, Czechia, France, Hungary, Israel
-
SanofiActive, not recruitingAdenocarcinoma Gastric | Gastrooesophageal CancerJapan, Belgium, Korea, Republic of, Spain, Russian Federation, Turkey
-
SanofiActive, not recruitingBreast Cancer Metastatic | Pancreatic Carcinoma MetastaticSpain, Korea, Republic of, Turkey, Chile, Netherlands, Russian Federation, Taiwan, United States, Argentina, Hungary
-
Yale UniversityBayerCompletedPancreatic CancerUnited States
-
Biotest Pharmaceuticals CorporationBiotestCompletedMultiple MyelomaUnited States
-
BayerCompletedNeoplasmsFrance, Moldova, Republic of
-
BayerImmunoGen and MorphoSysCompletedMesotheliomaBelgium, France, United States, Canada, Spain, Turkey, United Kingdom, Australia, Finland, Italy, Poland, Korea, Republic of, Netherlands, Russian Federation
-
National Cancer Institute (NCI)TerminatedLung NeoplasmsUnited States
-
BayerTerminatedSolid TumorsUnited States, Italy, France, Poland
-
University of Alabama at BirminghamRecruitingOvarian Cancer | Primary Peritoneal Cancer | Fallopian TubeUnited States
-
Biotest Pharmaceuticals CorporationBiotestCompletedMultiple MyelomaUnited States
-
ImmunoGen, Inc.CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Belgium, Spain, Israel, Australia, Ireland, Germany, Italy, Bulgaria, Czechia, Poland
-
Alessandro SantinImmunoGen, Inc.RecruitingEndometrial CancerUnited States
-
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.RecruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerChina
-
Duke UniversityNational Comprehensive Cancer NetworkWithdrawnBreast Cancer Triple NegativeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingPleural Malignant MesotheliomaUnited States, Canada
-
University of Colorado, DenverImmunoGen, Inc.RecruitingFallopian Tube Cancer | Peritoneal Cancer | Ovary CancerUnited States
-
ImmunoGen, Inc.GOG FoundationRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Korea, Republic of, Spain, Australia, Canada, United Kingdom, Italy, Czechia, Philippines, Israel, Belgium
-
BayerCompletedOvarian NeoplasmsBelgium, Spain, Moldova, Republic of, United States
-
Cairo UniversityRecruiting
-
ImmunoGen, Inc.Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, France, Belgium, Spain, Ireland, Italy, Australia, Canada
-
BayerImmunoGen, Inc.; MorphoSys AGCompletedNeoplasmsUnited States, Spain, United Kingdom, Korea, Republic of, Canada, France, Belgium, Australia, Singapore, Italy, Netherlands, Switzerland
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedStage IV Non-Small Cell Lung Cancer AJCC v7 | Stage IIIA Non-Small Cell Lung Cancer AJCC v7 | Stage III Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Non-Small Cell Lung Cancer AJCC v7 | Mesothelin PositiveUnited States
-
ImmunoGen, Inc.Active, not recruitingFallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Ovarian CancerUnited States, United Kingdom, Belgium, Spain, Canada, Georgia
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Recurrent Breast Carcinoma | Triple-Negative Breast CarcinomaUnited States
-
TakedaRecruitingOvarian Cancer | Solid TumorsJapan
-
University of OklahomaImmunoGen, Inc.WithdrawnEndometrial Cancer | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial AdenocarcinomaUnited States
-
AGO Research GmbHRecruitingRecurrent Epithelial Ovarian, Fallopian or Peritoneal CarcinomaGermany
-
BayerCompletedMedical OncologyUnited States, Belgium, Spain, France, Netherlands, Australia
-
ImmunoGen, Inc.Gynecologic Oncology GroupCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaUnited States, France, Canada, Spain, Switzerland, Belgium, Italy, United Kingdom, Ireland, Russian Federation, Bosnia and Herzegovina, Czechia, Serbia
-
SanofiCompletedNeoplasm MalignantJapan
-
Ohio State University Comprehensive Cancer CenterImmunoGen, Inc.; Clovis Oncology, Inc.Active, not recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Folate Receptor Alpha Positive | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Recurrent Uterine Serous Carcinoma | Recurrent Uterine Carcinosarcoma | Platinum...United States
-
ImmunoGen, Inc.Gynecologic Oncology Group; European Network of Gynaecological Oncological...Active, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Canada, Germany, China, France, Korea, Republic of, Belgium, United Kingdom, Serbia, Spain, Australia, Israel, Italy, Taiwan, Czechia, Bulgaria, Netherlands, Portugal, Poland, Russian Federation, Ukraine
-
Bio-Thera SolutionsUnknownHER2-Positive Solid TumorsChina
-
National Cancer Institute (NCI)Active, not recruitingPancreatic Adenocarcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8United States, Canada
-
ImmunoGen, Inc.Not yet recruitingRecurrent Ovarian Cancer | Folate Receptor-Alpha PositiveUnited States, Spain, Australia, Belgium, Canada, France, Ireland, Italy
-
ImmunoGen, Inc.CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States, Spain, Belgium, Canada
-
St. Jude Children's Research HospitalKazia Therapeutics LimitedCompletedBrain and Central Nervous System TumorsUnited States
-
Institut CurieCompletedMetastatic Breast Cancer, HER2 Negative Primary TumorFrance
-
Boehringer IngelheimTerminated
-
M.D. Anderson Cancer CenterImmunoGen, Inc.Completed
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC; ImmunoGen, Inc.Active, not recruitingEndometrial CancerUnited States
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted